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This review examines recent work on epigenetic mechanisms underlying animal models of
fear learning as well as its translational implications in disorders of fear regulation, such as
Post-traumatic Stress Disorder (PTSD). Specifically, we will examine work outlining roles of
differential histone acetylation and DNA-methylation associated with consolidation, reconsolidation, and extinction in Pavlovian fear paradigms. We then focus on the numerous
studies examining the epigenetic modifications of the Brain-derived neurotrophin factor
(BDNF) pathway and the extension of these findings from animal models to recent work
in human clinical populations. We will also review recently published data on FKBP5 regulation of glucocorticoid receptor function, and how this is modulated in animal models
of PTSD and in human clinical populations via epigenetic mechanisms. As glucocorticoid
regulation of memory consolidation is well established in fear models, we examine how
these recent data contribute to our broader understanding of fear memory formation. The
combined recent progress in epigenetic modulation of memory with the advances in fear
neurobiology suggest that this area may be critical to progress in our understanding of
fear-related disorders with implications for new approaches to treatment and prevention.
Keywords: amygdala, fear memory, consolidation, reconsolidation, extinction, biomarkers, PTSD

INTRODUCTION
Pavlovian fear conditioning has become a useful tool for the identification of the cellular and molecular mechanisms necessary for
the formation of fear memories (Levenson and Sweatt, 2005; Monsey et al., 2011; Mahan and Ressler, 2012; Zovkic and Sweatt, 2013;
Zovkic et al., 2013). Moreover, Pavlovian fear conditioning as a
model of traumatic memory formation has aided in the identification of potential intervention strategies, including extinction and
reconsolidation-based memory interventions for the alleviation of
traumatic fear memories (Andero and Ressler, 2012; Steckler and
Risbrough, 2012). Recent work examining the cellular and molecular mechanisms necessary for the formation of Pavlovian fear
memories has highlighted the significance of epigenetic mediation
of traditional genomic targets already known to be critical for the
formation of fear memories in animal models of post-traumatic
stress disorder (PTSD). This review will address the recent progress
that has been made in uncovering the epigenetic mechanisms necessary for auditory fear memory consolidation, reconsolidation,
and extinction. We then address the translation of these animal
findings into more recent work examining the correlation of epigenetic modifications at specific gene promoters associated with
clinical PTSD.

EPIGENETIC MECHANISMS REQUIRED FOR AUDITORY FEAR
MEMORY CONSOLIDATION
Decades of work have established that auditory fear memory
consolidation requires genomic signaling cascades to mediate
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the transcriptional and translational processes which ultimately
underlie fear memory formation (Johansen et al., 2011). Specifically, auditory fear conditioning results in the activation of
ERK/MAPK within lateral amygdala (LA) neurons (Schafe et al.,
2000). ERK/MAPK in turn translocates to the nucleus where it
phosphorylates the transcription factor CREB to mediate downstream transcriptional activation (Josselyn et al., 2001; Ressler
et al., 2002; Ploski et al., 2010). While much progress has been
made examining these traditional genomic signaling mechanisms,
it has become increasingly evident that additional mechanisms
likely also influence and regulate the transcriptional access necessary for synaptic plasticity and memory formation (Levenson
and Sweatt, 2005, 2006; Barrett and Wood, 2008; Jiang et al., 2008;
Zovkic and Sweatt, 2013; Zovkic et al., 2013). Thus in recent years
attention has turned to examining how “epigenetic” mechanisms
may regulate transcriptional access to genes which are critical for
memory formation.
Epigenetics involves the study of changes in gene expression which occur independent of alterations to the underlying DNA sequence. Two epigenetic mechanisms in particular
have been examined in memory formation and synaptic plasticity: post-translational modifications to chromatin structure
and DNA methylation (Levenson and Sweatt, 2005). Within
the nucleus, DNA is tightly condensed into chromatin consisting of eight histones: two copies each of H2A, H2B, H3, and
H4 as well as the linker histone H1. Each histone possesses an
N-terminus tail capable of undergoing multiple modifications,
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including acetylation, phosphorylation, and methylation (Levenson and Sweatt, 2005). While a few studies have identified the
regulation of histone methylation and phosphorylation accompanying fear conditioning in contextual fear paradigms (Chwang
et al., 2006; Gupta et al., 2010; Gupta-Agarwal et al., 2012), histone
acetylation has been more commonly studied within the context of learning and memory (Graff and Tsai, 2013). Positively
charged lysine residues on N-terminus histone tails restrict transcriptional access and the acetylation of these residues via histone
acetyltransferases (HATs) neutralizes the positive charges on the
histone tails to relax chromatin structure and promote accessibility for transcription factor binding (Varga-Weisz and Becker,
1998; Yang and Seto, 2007). Conversely, histone acetylation is negatively regulated by histone deacetylases (HDACs) which remove
acetyl groups from lysine residues and thus condense chromatin
structure and interfere with transcriptional access (Varga-Weisz
and Becker, 1998; Yang and Seto, 2007) (Figure 1).
Whereas histone acetylation has been widely associated with
transcriptional activation, DNA methylation has traditionally
been considered a static process associated with transcriptional
repression (Miranda and Jones, 2007). DNA methylation is the
process whereby methyl groups are added to cytosine residues
within the DNA sequence and the addition of these methyl groups
has been shown to inhibit transcriptional access to DNA, a process
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FIGURE 1 | Schematic diagram of histone and DNA-methylation
processes of epigenetic regulation of gene expression. The schematic
diagram demonstrates the primary known functions of the different
enzymes referred to within the review. (A) Histone acetyltransferases (HAT)
add acetyl groups to histones, generally associated with relaxing wound
DNA. (B) Histone deacetylases (HDAC) remove those acetyl groups. (C)
Histone methyltransferases (HMT) add methyl groups to histones, generally
associated with tightening wound DNA. (D) Histone demethylases (HDM)
remove those methyl groups. (E) DNA methyltransferases (DNMT) add
methyl groups to DNA, sometimes associated with DNA silencing.
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which is catalyzed by DNA methyltransferases (DNMTs) (Miranda
and Jones, 2007). While the existence of dynamic DNMT activity
within the mature central nervous system (CNS) has been documented, preliminary evidence has emerged to reveal a role for
Gadd45b as a regulator of active DNA demethylation within the
CNS (Leach et al., 2012; Sultan et al., 2012) (Figure 1).
Early evidence of a role for chromatin modifications accompanying learning in mammalian models of learning and memory
was revealed by a study employing a contextual fear conditioning paradigm known to regulate the ERK/MAPK–CREB genomic
signaling pathway. This study from David Sweatt’s group revealed
robust regulation of histone H3 acetylation, but not H4, 60 min
following contextual fear conditioning in area CA1 of the hippocampus (Levenson et al., 2004), a pattern of findings which
has been well-replicated (Lubin and Sweatt, 2007; Miller et al.,
2008). Further, increasing histone acetylation via HDAC inhibition
has been well documented to enhance memory consolidation in
a variety of hippocampal-dependent learning paradigms, including object recognition and contextual fear conditioning (Levenson
et al., 2004; Stefanko et al., 2009; but see Sintoni et al., 2013).
While regulation of histone H3 and H4 acetylation have been
most commonly examined and acetyl-H3 regulation is most
widely reported, evidence has emerged implicating the regulation
of histone H2B acetylation accompanying contextual fear and spatial learning in the hippocampus suggesting not only that there
may be differential regulation of specific histones with varying
types of memory formation but also that a closer look at the
regulation of other histones with learning and memory is warranted (Bousiges et al., 2013). Further, it is worth noting that
learning-related alterations in histone acetylation have not been
ubiquitously observed. One such study employing an invertebrate
model of context-signal memory, whereby presentation of a danger stimulus elicits an escape response, demonstrated that while
HDAC inhibition was capable of enhancing the escape response
and accompanying levels of histone acetylation with weak training procedures, only strong training was capable of resulting in
robust regulation of histone acetylation (Federman et al., 2009).
Further, another study employing a food aversion paradigm in
the mollusk revealed asymmetric regulation of histone acetylation accompanying training (Danilova et al., 2010). These studies
suggest that there may be important training-related gradients
which determine the extent to which histone acetylation is regulated by learning and that there may be asymmetric differences
in the engagement of histone acetylation accompanying training.
However, despite these findings from invertebrate learning and
memory models, the training parameters necessary to induce alterations in histone acetylation events or the existence of asymmetric
regulation within mammalian models has yet to be determined.
Further examination of the regulation of histone acetylation in
mammalian models has demonstrated that the observed trainingrelated regulation of histone H3 acetylation is downstream of
ERK/MAPK signaling, as the MEK inhibitor U0126 was found
to impair the acetylation of H3 (Levenson et al., 2004). Inhibition of ERK/MAPK signaling has also been found to impair
histone acetylation regulation in an invertebrate model of food
aversion learning (Danilova et al., 2010) and in the consolidation
of auditory fear memories (Monsey et al., 2011). These findings
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implicate the interplay of traditional genomic signaling cascades
and epigenetic mechanisms. They also suggest the existence of a
level of epigenetic regulation of transcriptional processes necessary for memory formation, which has only become more widely
appreciated within the last decade.

EPIGENETIC UNDERPINNINGS OF FEAR MEMORY
HISTONE ACETYLATION MEDIATES AUDITORY FEAR MEMORY
CONSOLIDATION

Early work examining the necessity of epigenetic mechanisms
in the regulation of memory formation has largely employed
hippocampal-dependent memory paradigms (Levenson et al.,
2004; Miller and Sweatt, 2007; Lubin et al., 2008; Miller et al., 2008;
Stefanko et al., 2009). More recent work has begun to examine the
role of epigenetic mechanisms in amygdala-dependent memory
processes. In agreement with the evidence for regulation of histone acetylation with contextual fear conditioning, a recent series
of studies has demonstrated that auditory fear conditioning also
results in an increase in histone H3 but not H4 acetylation in
the LA (Monsey et al., 2011). Further, this study demonstrated

FIGURE 2 | Schematic diagram of different phases of fear learning, and
predicted effects of inhibiting histone acetyltransferase, histone
deacetylase, or DNA methyltransferase. The schematic diagram illustrates
the predicted outcome of pharmacological inhibition of histone and DNA
modifying enzymes on the primary aspects of fear memory. (Top) When
treated with inhibitors during the consolidation phase of fear conditioning,
short-term memory (STM) tests are not generally effected, but long-term
memory (LTM) expression is impaired with HAT and DNMT inhibition or
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that increasing histone acetylation via HDAC inhibition in the
LA resulted in enhanced auditory fear memory consolidation,
i.e., freezing during long-term memory was enhanced whereas
short-term memory was not affected (Figure 2).
Despite the documented increase in histone H3 acetylation with
auditory fear conditioning and facilitation of fear memory consolidation via HDAC inhibition, these findings did not directly address
the necessity of histone acetylation in fear memory consolidation.
To date, while many proteins have been identified which possess
HAT activity, three in particular have been widely examined within
the field of learning and memory: E1a-associated protein (p300),
CREB binding protein (CBP), and p300-CBP-associated protein
(PCAF) (Barrett and Wood, 2008). Much of the work examining
the role of these HATs in memory processes have employed transgenic mouse models of varying degrees from brain-region specific
to full knockout of HAT proteins (Oike et al., 1999; Alarcon et al.,
2004; Korzus et al., 2004; Wood et al., 2005, 2006; Oliveira et al.,
2007, 2011; Valor et al., 2011). From this wide collection of studies
only two have revealed deficits in amygdala-dependent auditory
fear memory (Oike et al., 1999; Alarcon et al., 2004), while many

increased with HDAC inhibition. (Middle) When inhibitors are given after a
brief memory reactivation, they may affect memory reconsolidation
processes. In this case, there are no predicted effects on short-term memory
post-reactivation (PR-STM); however, PR-LTM is impaired with HAT and
DNMT inhibition or increased with HDAC inhibition. (Bottom) When inhibitors
are given following extinction training, HAT inhibition is predicted to impair
extinction retention while HDAC inhibition is predicted to enhance extinction
retention.
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report deficits in the hippocampal-dependent tasks of contextual
fear and the novel object recognition paradigm (Korzus et al.,
2004; Wood et al., 2005, 2006; Oliveira et al., 2007, 2011; Valor
et al., 2011).
Recently, pharmacological inhibitors of HAT activity have
become commercially available and these agents have been
employed in specific brain regions to examine more targeted
inhibition of HAT proteins in conjunction with learning and memory paradigms, independent of the potential developmental confounds with transgenic models (Marek et al., 2011; Wei et al., 2012;
Zhao et al., 2012). Inhibition of HAT activity using either garcinol
or c646 administration accompanying auditory fear conditioning has been found to inhibit training-related changes in histone
acetylation within the LA and coordinately inhibit auditory fear
memory consolidation, in a temporally graded manner (Maddox
et al., 2013a,b). Further, these studies demonstrated that inhibition of HAT activity shortly following auditory fear conditioning
also impaired learning-related enhancements in auditory-evoked
field potentials (AEFPs) within the LA, a commonly studied neurophysiological correlate of auditory fear memory consolidation
(Quirk et al., 1995; Rogan et al., 1997). It is worth considering that
given the large sequence homology between CBP and p300, and
given the ability of CBP/p300 to structurally associate with PCAF
to regulate histone acetylation (Schiltz et al., 1999), making claims
about the necessity of one HAT over another using these pharmacological inhibitors is not warranted. While these data do reveal a
critical role for HAT activity in the consolidation of auditory fear
memories, more attention is needed to examine the specific contributions each of these HATs may make either independently or in
combination with one another to promote learning and memory.
A recent study examining the role of PCAF in auditory fear
memory extinction suggests that PCAF in the infra-limbic prefrontal cortex (ILPFC) has a selective role in the consolidation
of auditory fear memory extinction (Wei et al., 2012). However
it is worth noting that in an experiment from this study, the
PCAF inhibitor H3-CoA-20-Tat was infused into the prelimbic
PFC (PLPFC) immediately following auditory fear conditioning
and was found to enhance consolidation of auditory fear memory.
A role for the PLPFC in expression and consolidation of fear memories has been established (Vidal-Gonzalez et al., 2006; Corcoran
and Quirk, 2007; Choi et al., 2010). Further, a role for brain-derived
neurotrophin factor (BDNF) in the PLPFC has been identified as a
key mediator of fear memory consolidation (Choi et al., 2010), and
as recent work has shown that HDAC administration can enhance
levels of BDNF mRNA (Zeng et al., 2011) (and see below), the
mechanism though which inhibition of HAT activity in the PLPFC
results in enhanced fear memory consolidation remains unclear.
DNA METHYLATION MEDIATES AUDITORY FEAR MEMORY
CONSOLIDATION

While traditionally considered a stable and enduring transcriptional constraint, studies examining the role of DNA methylation
in learning and memory have revealed dynamic regulation of
DNA methylation (Miller and Sweatt, 2007; Lubin et al., 2008;
Feng et al., 2010; Han et al., 2010). As DNMTs serve to add
methyl groups to CpG islands on DNA sequences to silence gene
expression, traditional logic suggests that their inhibition would
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enhance memory formation via transcriptional activation. Conversely, studies have shown that inhibition of DNMT activity
interferes with memory consolidation processes in a variety of
hippocampal-dependent learning paradigms, including contextual fear, cocaine-induced place preference, and Morris water maze
learning (Miller and Sweatt, 2007; Lubin et al., 2008; Feng et al.,
2010; Han et al., 2010). In agreement with these findings, auditory
fear conditioning has recently been associated with an increase in
DNMT3a protein within the LA (Monsey et al., 2011). Inhibition
of DNMT activity within the LA at or near the time of training
results in impaired fear memory consolidation, suggesting that
DNMT activity is critical for amygdala-dependent fear memory
consolidation as it is in the hippocampal contextual fear memory system (Monsey et al., 2011). In support of these findings,
experiments employing slice electrophysiology, revealed that inhibition of DNMT activity impairs long-term potentiation (LTP), a
well established model of synaptic plasticity, from both thalamic
and cortical input pathways to the amygdala. Thus, this pattern
of findings clearly implicates DNMT activity in the establishment of synaptic plasticity and ultimately auditory fear memory
consolidation.
While these early studies implicate a role for DNMT activity
in memory consolidation processes, only recently has evidence
emerged to suggest the existence of a DNA demethylase within
the CNS. Gadd45b has been proposed to be a regulator of active
DNA demethylation within the adult CNS (Leach et al., 2012;
Sultan et al., 2012). Both of these studies employ a genetic knockout model of Gadd45b yet draw contrasting conclusions regarding the role of Gadd45b in memory processes. While one study
revealed enhancements in contextual fear memory consolidation
with mild and moderate training parameters and implicates a
role of Gadd45b as a negative regulator of contextual fear memory formation (Sultan et al., 2012), the other study demonstrated
impaired contextual fear memory consolidation and is in line with
a permissive role for Gadd45b in memory formation (Leach et al.,
2012). However, both studies failed to demonstrate an effect on the
consolidation of amygdala-dependent auditory fear memory, suggesting that the identification of an active DNA demethylase in the
auditory (or cued) fear memory system has yet to be determined.
While the findings of enhanced memory formation accompanying Gadd45b knockout are in line with the findings demonstrating
memory consolidation deficits associated with DNMT inhibition
(Miller and Sweatt, 2007; Miller et al., 2008), there remains a
lack of cohesion regarding the role of Gadd45b in contextual
fear memory formation. These findings demonstrate a clear need
for further investigation into the underlying mechanism through
which Gadd45b may function as a regulator of memory formation.
Although multiple labs have now documented fear memory
consolidation deficits accompanying DNMT activity inhibition
in either the amygdala or the hippocampus, the findings are still
somewhat counter-intuitive. However, a few studies have provided
evidence for a possible mechanism underlying these memory
deficits. A series of studies has revealed an interaction between
DNA methylation and histone acetylation in the consolidation of
contextual and auditory fear memories (Miller et al., 2008; Monsey
et al., 2011). Both studies demonstrated that memory consolidation deficits accompanying DNMT inhibition were associated
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with impaired training-related regulation of histone acetylation
but that consolidation and histone acetylation deficits could be
rescued with HDAC inhibition. Thus, these findings suggest that
one method by which DNMT inhibition may result in memory
consolidation deficits is via its inhibition of the critical trainingrelated regulation of histone acetylation and suggest that there is a
critical cooperation between these epigenetic mechanisms which
is necessary for memory consolidation.
Another compelling hypothesis for the memory consolidation
deficits associated with DNMT inhibition concerns the differential effect on DNA-methylation patterns across various subsets of
genes. First, work has suggested that the methyl-binding protein,
MeCP2, interacts with the transcription factor CREB1 to regulate
the activation of CRE-mediated genes, suggesting that methylation and the binding of methyl-binding proteins (MBPs) at CRE
sites is associated with transcriptional activation (Chahrour et al.,
2008). In agreement with this finding, work from Farah Lubin’s
group (Gupta et al., 2010) demonstrated that contextual fear conditioning results in an increase in DNA methylation within the
zif268 promoter region and a corresponding increase in zif268
mRNA expression. Moreover this group demonstrated an increase
in MeCP2 within the zif268 promotor region associated with DNA
methylation, suggesting that indeed methylation is required for the
activation of CRE-mediated genes such as zif268. Thus these findings may suggest that inhibition of DNMT activity near the time of
fear conditioning results in consolidation deficits via the inhibition
of CRE-mediated genes which are critical for consolidation, such
as zif268 (Maddox et al., 2011), and suggest that DNA methylation
can in some cases be associated with transcriptional activation.
An extension of this hypothesis concerns the possibility that
DNMT inhibition may offset the balance of memory-promoting
(e.g., the CRE-mediated IEG zif268) and memory-suppressive
genes. Contextual fear conditioning has been associated with
demethylation and a corresponding increase in reelin mRNA, a
memory-promoting gene, in the hippocampus. Conversely, contextual fear learning leads to a hypermethylation of the memorysuppressive gene protein phosphatase (PP1) with a corresponding reduction in PP1 mRNA (Miller and Sweatt, 2007). Further,
DNMT inhibition was found to reverse these changes, such that
the training-induced methylation of PP1 was impaired and thus
PP1 mRNA was increased. These data suggest that one manner in
which DNMT inhibition results in impaired memory consolidation is via the demethylation of memory-suppressing genes, such
that their enhanced expression results in memory impairment.
Further, it remains possible that the findings of DNMT inhibition’s
effects on (1) the reduction of training-related changes in histone
acetylation, (2) ability to enhance the transcription of memorysuppressive genes, and (3) its impairment of memory-promoting
genes, especially the induction of CRE-mediated IEGs, are not
mutually exclusive events. This suggests that these effects should
be considered in concert when further examining the mechanism
through which DNMT inhibition impairs memory consolidation.

EPIGENETIC REGULATION OF AUDITORY FEAR MEMORY
RECONSOLIDATION
Another growing field of study within the realm of epigeneticmediation of fear memories is the examination of a role for
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epigenetic processes in the reconsolidation of auditory fear
memories. Reconsolidation is the phenomenon whereby retrieval
of a previously acquired memory results in the induction of a
period of instability during which the memory may be updated,
either strengthened or weakened, prior to being re-stabilized
(Nader et al., 2000; Tronson and Taylor, 2007). An early study
noted the existence of epigenetic mechanisms in contextual fear
memory reconsolidation by revealing the retrieval-induced regulation of histone acetylation in area CA1 of the hippocampus via
the NF-κB/IKK (Nuclear Factor Kappa-light-chain-enhancer of
activated B cells/inhibitor of NF-κB kinase) pathway (Lubin and
Sweatt, 2007). Within the last few years, a series of studies has further contributed to this early work by outlining a critical role for
epigenetic mechanisms in auditory fear memory reconsolidation.
As with initial auditory fear memory consolidation, retrieval of a
previously acquired auditory fear memory was found to result in
a retrieval-dependent increase in histone H3 acetylation, but not
regulation of H4 acetylation in the LA (Maddox and Schafe, 2011).
Moreover, HDAC inhibition accompanying auditory fear memory retrieval was found to enhance memory reconsolidation in
a retrieval-dependent and temporally graded manner, suggesting
that as with auditory fear memory consolidation, HDAC activity
appears to negatively regulate fear memory reconsolidation within
the LA (Figure 2). To further explore the role of histone acetylation
in fear memory reconsolidation, more recent work has revealed
that HAT activity is critical in mediating retrieval-related alterations in histone acetylation and that HAT inhibition impairs fear
memory reconsolidation (Maddox et al., 2013a,b). Results from
both studies have demonstrated that inhibition of HAT activity
results in a long-lasting and robust reconsolidation deficit which
is dependent on memory retrieval, insensitive to spontaneous
recovery, reinstatement, and fear renewal in a novel context. Further, these studies demonstrated that inhibition of HAT activity
accompanying fear memory retrieval was capable of reversing the
underlying memory-associated changes in AEFPs, suggesting that
this memory intervention strategy is effective at impairing fear
memory reconsolidation at the level of behavior and at the level
of synaptic plasticity, in vivo. Moreover, as garcinol is a naturally
occurring HAT inhibitor, these data were the first to document
the pre-clinical efficacy of a naturally occurring pharmacological
strategy in conjunction with reconsolidation-based fear memory
intervention. These findings highlight the potential for future
identification of naturally occurring compounds to use in the
treatment of fear and anxiety disorders (Maddox et al., 2013a).
Comparatively fewer studies have examined the role of DNA
methylation in auditory fear memory reconsolidation processes;
however in agreement with the findings of studies of auditory
fear memory consolidation, intra-LA inhibition of DNMT activity at or near the time of auditory fear memory retrieval has
been shown to impair the reconsolidation of memory (Maddox and Schafe, 2011). Moreover, inhibition of DNMT activity
accompanying fear memory retrieval was found to result in a
retrieval-dependent, temporally graded deficit which is insensitive
to spontaneous recovery, reinstatement, and fear renewal. While
these data demonstrate a critical role for DNMT activity in reconsolidation as one method to alleviate existing fear memories, a role
for DNA methylation and DNMT activity has yet to be revealed
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for the consolidation of fear extinction memory, the other widely
explored method for alleviating existing fear memories.

EPIGENETIC REGULATION OF FEAR MEMORY EXTINCTION
Rodent models of fear memory extinction have proven quite useful
in making suggestions about relevant pharmacological manipulations which may be implemented in cognitive-behavioral therapy
for the treatment of phobias, anxiety disorders, and PTSD (Andero
and Ressler, 2012). Extinction involves the repeated presentation
of the fear-invoking conditioned stimulus (CS) in the absence of
the unconditioned stimulus (US), and results in the formation a
new memory which inhibits the expression of the existing fear
memory (Myers and Davis, 2007). Given that HDAC inhibitors
have been widely reported to enhance memory, recent work has
turned toward examining the potential for HDAC inhibition to
enhance extinction memory as it may have clinical implications.
A few labs have now provided evidence for the benefit of HDAC
inhibition on fear extinction learning by demonstrating that systemic HDAC inhibition is capable of facilitating extinction for
auditory fear memory (Lattal et al., 2007; Bredy and Barad, 2008;
Fujita et al., 2012; Itzhak et al., 2012) (Figure 2) and facilitating
extinction of cocaine conditioned place preference (Malvaez et al.,
2010).
However, there is some evidence to suggest that there may
be limits on the effectiveness of HDAC inhibition in facilitating
extinction. One such study demonstrated that intra-hippocampal
or intra-ILPFC administration of the HDAC inhibitor sodium
butyrate (NaB) was capable of enhancing contextual fear memory
extinction, but only under conditions when extinction training
was weak, i.e., NaB administration was not effective in facilitating extinction using more stringent extinction sessions (Stafford
et al., 2012). The lack of a facilitation of extinction with HDAC
inhibition in conjunction with stronger extinction parameters may
suggest the presence of a ceiling effect. However, extinction facilitation accompanying HDAC inhibition has not always proven
successful (Kilgore et al., 2010). Another study has suggested that
while overexpression of HDAC1 in the hippocampus facilitates
contextual fear extinction, inhibition of HDAC1 correspondingly
results in impaired extinction (Bahari-Javan et al., 2012). As HDAC
inhibition has been associated with enhanced extinction in a number of studies using pharmacological approaches such as NaB,
Vorinostat, or TSA, HDAC inhibitors which inhibit multiple classes
of HDACs, it remains unclear if different classes of HDACs make
different contributions to fear memory extinction. The lack of
a cohesive role for HDAC activity in fear memory extinction
clearly suggests that this is an area of work which requires further
investigation.
Another study has demonstrated that inhibition of PCAF activity within the ILPFC impairs the consolidation of extinction
for an auditory fear (Wei et al., 2012), data which implicate a
critical role for histone acetylation via HATs in fear memory
extinction. However, it is worth noting that while many studies have demonstrated extinction enhancements accompanying
HDAC inhibition, one study has shown that inhibition of the HAT
activity of p300/CBP paradoxically enhances extinction memory
(Marek et al., 2011). The existence of the same behavioral outcome
(i.e., enhanced extinction via both inhibition and enhancement of
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histone acetylation) is somewhat perplexing and further research
is warranted to uncover the mechanism underlying these findings.
As this lab has provided evidence for a critical role for PCAF in the
consolidation of auditory fear extinction (Wei et al., 2012) further
investigation might reveal a unique relationship between these
HATs and their role in the regulation fear memory extinction.
Intriguingly, a recent study examining the potential chromatin
modifications in the ventral-medial PFC (vmPFC) occurring
with extinction of conditioned place aversion (CPA) accompanying morphine withdrawal (Wang et al., 2012) demonstrated
increased AcH3 and AcH4 following extinction. This study further demonstrated that intra-vmPFC administration of the partial
NMDA-receptor agonist d-cycloserine (DCS) resulted not only in
enhanced CPA extinction, but also facilitated extinction-related
increases in AcH3 and AcH4. As there is already evidence for the
efficacy of DCS in the treatment of fear memory in rodent models (Walker et al., 2002) and in phobias in a clinical population
(Ressler et al., 2004), these data may suggest that one unappreciated
mechanism through which DCS may be effective in promoting extinction-related plasticity is via enhancement of chromatin
modifications which are downstream of NMDAR activation.

TRANSLATING ANIMAL MODELS TO THE CLINIC:
EPIGENETIC MODIFICATIONS OF GENES ASSOCIATED WITH
FEAR AND ANXIETY DISORDERS
Much work has revealed the regulation of global epigenetic
alterations, especially histone acetylation and DNA methylation,
accompanying both auditory fear conditioning and memory
retrieval in the amygdala and accompanying contextual fear conditioning in the hippocampus. Additionally, some progress has been
made in revealing the epigenetic regulation of specific genes associated with fear memory. Animal models examining the impact of
early-life trauma, stress, and adversity as a risk factor for the future
development of psychiatric disorders appear to have gained support from recent studies in human clinical populations. Moreover,
it is the examination of epigenetic-modifications associated with
specific genes which has recently been explored within the context of clinical PTSD and other psychiatric disorders. Given recent
work examining epigenetic risk factors associated with the development of PTSD, we now review work employing animal models
of epigenetic regulation of anxiety and fear associated genes which
has been translated into human clinical populations, including
epigenetic modifications of glucocorticoid receptor (GR) function
including FKBP5, Nr3c1, and the BDNF pathways.
THE BDNF-TrKB PATHWAY AND ITS DOWNSTREAM
EFFECTORS
Brain-derived neurotrophin factor is a neurotrophic factor which
has been widely implicated in nervous system development, synaptic plasticity, and has been shown to be highly enriched in brainregions associated with emotional learning including the amygdala, hippocampus, and PFC (Hofer et al., 1990). Importantly,
support for a role for BDNF in emotional learning in animal models has been recently translated to PTSD in humans, as illuminated
by the finding that individuals with the BDNF polymorphism
Val66Met have impaired fear memory extinction (Soliman et al.,
2010). While a role for the BDNF peptide and its receptor, TrkB,
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have been well established in auditory fear conditioning (Rattiner
et al., 2004; Choi et al., 2010; Andero et al., 2011), additional insight
into the epigenetic mechanisms regulating the BDNF pathway and
its role in PTSD have been investigated by a number of groups.
Brain-derived neurotrophin factor consists of nine 50 -noncoding exons, each possessing individual promoter regions and
one 30 -coding exon (IX) which codes for the BDNF pre-protein
amino acid sequence (Aid et al., 2007). The existence of these
nine individual promoter regions within the BDNF gene sequence
allows for the potential for unique BDNF transcripts with differential regulatory regions and has been proposed to ultimately
underlie functional differences in BDNF transcription (e.g., Rattiner et al., 2004). Due to this potential for functional differences in
BDNF accompanying differential regulation of individual BDNF
exons, studies exploring the epigenetic regulation of BDNF have
examined multiple BDNF exons. Using a contextual fear memory paradigm, it was determined that context-shock associations
resulted in a selective decrease in DNA methylation within BDNF
exon IV and a corresponding increase in BDNF exon IV mRNA in
the hippocampus (Lubin et al., 2008). In addition, a study employing a PTSD model, examining the impact of prior-stress experience
on subsequent contextual fear memory formation, determined
that prior-stress experience resulted in enhanced freezing levels and correspondingly an increase in BDNF exon I and IV
mRNA in the hippocampus (Takei et al., 2011). This study further revealed an increase in histone H3 and H4 acetylation within
exon I and IV BDNF promoters, implicating a role for histone
acetylation-mediated enhancement of BDNF mRNA accompanying stress-enhanced contextual fear memory formation. While this
study is in agreement with the previous implication of epigenetic
regulation of BDNF exon IV in contextual fear memory formation,
the finding of significant regulation of BDNF exon I regulation
with stress-enhanced contextual fear learning may suggest that
stress allows for more extensive epigenetic modifications within
the BDNF gene to promote fear memory formation. However, it is
worth noting that a previous study from this group examining the
epigenetic regulation of BDNF following a single session of immobilization stress in the hippocampus revealed a reduction in AcH3
association with BDNF exon I and IV promoters and a corresponding decrease in BDNF I and IV transcript mRNA 2 h following
stress, but not 24 h (Fuchikami et al., 2009). As these findings suggest that previous stress can enhance histone acetylation-mediated
BDNF transcription accompanying contextual fear conditioning
1-week later (Takei et al., 2011), the immediate post-stress reduction in BDNF transcription, and histone-modification seems at
odds with this hypothesis. Thus, more work is necessary to examine how prior-stress experience can enhance histone acetylationmediated BDNF transcription at this later time point, when stress
experience itself does not appear to have a long-lasting (24 h later)
effect on BDNF transcription in the hippocampus.
Although studies examining the regulation of histone
acetylation-mediation of BDNF transcription have not revealed
enduring changes in acetylation-mediated regulation of specific
BDNF promoter transcripts, suggesting that chromatin modifications are transiently mediated following stress and/or fear conditioning, work examining DNA-methylation of BDNF promoters
has revealed more enduring epigenetic regulation of BDNF. Using
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a psychosocial-stress PTSD model in rats, methylation of BDNF
promoters was examined following a 1 month stress period (Roth
et al., 2011). BDNF exon IV was found to have enhanced levels
of CpG methylation in both the dentate gyrus and area CA1 of
the hippocampus in the stress exposed group and a corresponding reduction in BDNF exon IV mRNA levels. However, this study
failed to find stress-related alterations in BDNF DNA methylation in the amygdala and PFC. These data suggest that there is
a robust regulation of DNA methylation at CpG islands within
BDNF exon IV in the hippocampus which is a consequence of
stress. It remains unclear why no changes were observed in the
amygdala and PFC, both structures which have been shown to
be affected by experience with stress (Rodrigues et al., 2009).
However, the epigenetic-regulation of BDNF exon IV in the hippocampus is in agreement with the aforementioned findings and
signifies that exon IV in particular undergoes robust epigeneticmodifications accompanying contextual fear memory formation
and stress exposure. Thus this BDNF promoter/exon regulation is
likely key in the development of a PTSD-like condition in these
animal models.
Translational work employing a rodent model of early-life maltreatment and trauma has demonstrated long-lasting epigeneticmediation of BDNF transcription (Roth et al., 2009). In this study,
infant rats were exposed to a stressed, “abusive” mother for 30 min
per day during the first post-natal week or were cross-fostered
by a non-abusive mother for the same period of time. Upon
adulthood it was determined that those rats who experienced
maltreatment by the abusive mother had significant reductions
in total BDNF mRNA (exon IX) in the hippocampus, compared
to the cross-fostered non-maltreated adults, suggesting that there
is a long-lasting effect of early-life maltreatment on BDNF regulation. Further, this study revealed an increase in BDNF exon IV and
IX DNA methylation in the PFC of adult rats with a history of early
post-natal maltreatment, suggesting that early-life stress is capable
of resulting in long-lasting epigenetic changes at BDNF promoters
which result in long-lasting BDNF transcription deficits.
These studies reveal a role for epigenetic-mediated regulation of
BDNF transcription accompanying contextual fear memory formation, and demonstrate an enhancement of epigenetic-mediated
BDNF transcription with prior-stress experience. To date only one
study has examined the potential role for epigenetic-mediation
of BDNF transcription accompanying fear memory extinction
(Bredy et al., 2007). This study demonstrated that while auditory
fear conditioning was associated with increased AcH3 at BDNF
I and IV exon promoters in the PFC, extinction was associated
with a decrease in AcH3 recruitment to the exon I promoter but
increased AcH4 at BDNF exon IV promoter. Further, while exon
IV mRNA was enhanced with fear conditioning, extinction was
found to result in a more profound increase in exon IV mRNA
and also to induce an increase in exon I mRNA. These data
are the first to reveal differential regulation of BDNF transcripts
in the PFC accompanying fear memory formation and extinction learning and suggest that there may be different epigeneticmediation of BDNF transcription for different forms of memory,
i.e., consolidation versus extinction.
While these early studies have laid a firm foundational role for
epigenetic regulation of BDNF accompanying fear memory and/or
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stress exposure in a variety of paradigms, recent work has identified epigenetic regulation of homer1a, a gene variant of homer1
and a downstream transcriptional target of BDNF-TrkB signaling
(Mahan et al., 2012). Using a fear conditioning paradigm which is
capable of instating both auditory and contextual fear memoryrelated plasticity, this study revealed that fear conditioning was
associated with an increase in histone H3 acetylation within the
homer1 promoter region within the hippocampus while a decrease
in histone H3 methylation within the homer1 promoter region was
observed within the amygdala (Figure 3). Both of these changes
in histone H3 modifications were associated with an increase in
homer1a mRNA, suggesting that there is differential and brainregion specific epigenetic regulation of homer1a expression. As
with the earlier suggestion of differential epigenetic regulation of
BDNF transcription for fear memory formation and extinction
memory in the PFC (Bredy et al., 2007) these data may suggest that contextual fear memories mediated by the hippocampus
may require histone acetylation-mediated homer1a transcription,
whereas auditory fear memories mediated by the amygdala may
require a decrease in H3 methylation to induce critical regulation
of homer1a with memory formation.

As noted earlier, while a variety of animal models of fear
and anxiety disorders have demonstrated epigenetic regulation
of BDNF, only a few studies have revealed the potential role for
epigenetic regulation of BDNF in human clinical populations.
For example, a pair of studies has examined post-mortem differences in epigenetic regulation of BDNF in suicidal behavior
(Keller et al., 2010, 2011). Examination of BDNF in Wernike’s area
revealed increased BDNF promoter IX methylation with a corresponding decrease in BDNF mRNA and protein levels in suicide
subjects (Keller et al., 2010). Despite this finding, no relationship with TrkB promoter methylation and suicide was revealed
(Keller et al., 2011). The failure to find epigenetic regulation of
TrkB receptor in suicidal behavior may be supported by the lack
of consistent findings regarding regulation of TrkB expression in
stress-mediated rodent models of PTSD (Smith et al., 1995a,b;
Takei et al., 2011). Examination of post-mortem epigenetic modifications in depressed patients who underwent antidepressant
treatment has also been associated with a decrease in H3K27
trimethylation at BDNF promoter IV in the PFC and subsequent
increased BDNF mRNA. However, no difference in H3K27 was
observed within BDNF promoter IV for those patients not on

A

B

FIGURE 3 | Example of BDNF-mediated transcriptional activation,
through epigenetic regulation of the homer1a synaptic plasticity
gene in hippocampus and amygdala (Mahan et al., 2012). Fear
conditioning rapidly increases BDNF-signaling in both the hippocampus
and amygdala and results in activation of the TRKB pathway that
activates MEK and ERK. ERK further phosphorylates CREB which is
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then translocated to the nucleus where it binds to CRE sites in the
promoter region of homer1a. CREB subsequently recruits CBP which
induces specific histone changes (A) increased acetylation in the
hippocampus and (B) decreased methylation in the amygdala, both of
which result in increased homer1a transcription (Figure courtesy of
Amy Mahan, PhD).
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antidepressant treatment (Chen et al., 2011). While these studies
suggest a correlation between post-mortem epigenetic modifications at BDNF promoters, it is unclear how these differences relate
to functional differences in BDNF transcription which underlie
depression or suicide behavior in vivo.
Despite the suggestion of a role for epigenetic modulation
of BDNF activity in depression and suicide, only one study has
demonstrated a modest association between increased methylation of one BDNF CpG site with current PTSD status (Smith
et al., 2011). Moreover, although previous reports have noted
lower levels of BDNF from blood serum in PTSD populations (Dell’Osso et al., 2009; Berger et al., 2010; but see Hauck
et al., 2009), it is unclear how this reduction relates to either
a risk factor for the development of PTSD or is rather a consequence of PTSD. Despite this preliminary evidence, a recent
model relating genetic risk factors associated with impaired fear
extinction such as the BDNF val66met polymorphism, potential
epigenetic-modifications associated with early-childhood adversity and trauma, and adulthood trauma has emerged to implicate a role for BDNF function in the comorbidity of PTSD and
bipolar disorder (Rakofsky et al., 2012). This model, with support from animal studies suggests that there may be a “critical
period” in development during which early-life trauma or stress
can most readily result in epigenetic modifications on genes associated with stress and PTSD which later impact the likelihood

for the future development of PTSD. In support of this model,
data have demonstrated epigenetic-modifications associated with
genes which regulate GR function in early-childhood adversity
and subsequent risk for the development of PTSD. Further, as
work has suggested that glucocorticoid exposure can influence
BDNF expression (Gourley et al., 2009), it is likely that with further examination of these genes and the interactions amongst
them, a role for epigenetic modifications of BDNF may be revealed
for PTSD.

EPIGENETIC MODIFICATIONS OF FKBP5 AND
GLUCOCORTICOID RECEPTOR FUNCTION
A role for the hypothalamic-pituitary adrenal (HPA) axis in
stress and fear memory has been well appreciated (Roozendaal et al., 2009), and one important target of HPA activity
is the regulation of GR activity. GR translocation is mediated by the GR co-chaperone protein FK506 binding protein 5
(FKBP5) which is associated with the chaperone heat shock protein 90 (hsp90) to form a chaperone complex which regulates
GR dynamics (Hubler and Scammell, 2004). Typically FKBP5
is regulated via a negative feedback loop such that GR activation promotes an increase in FKBP5, which limits GR translocation to the nucleus and GR-dependent transcriptional activation (Binder, 2009; Figure 4). Many FKBP5 polymorphisms have
been identified and evidence has emerged to suggest that these

A

B

FIGURE 4 | FKBP5 regulation of GR function, and DNA
methylation regulatory sites within the FKBP5 Gene (A)
Schematic diagram of FKBP5 regulation of Glucocorticoid
Receptor (GR) function. FKBP5 protein acts as an inhibitory
chaperone, preventing GR translocation to the nucleus. With
increasing cortisol binding, FKBP5 is displaced by FKBP4, allowing for
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translocation and gene activation, with more FKBP5 mRNA produced
as one of the GR-sensitive genes, completing the intracellular
negative feedback loop. (Figure courtesy of Elisabeth Binder). (B)
DNA methylation of the FKBP locus, in which significant DNA
methylation was observed in the promoter region, Intron 2 and intron
7 of the FKBP5 gene (Figure adapted from Klengel et al., 2013).
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polymorphisms impact cortisol response. Such findings suggest
that individuals carrying these polymorphisms may have maladaptive responses to stress and thus may be at enhanced risk
for developing psychiatric disorders (Ising et al., 2008; Mahon
et al., 2010; Touma et al., 2011). Indeed HPA dysregulation and
GR resistance, mediated by alterations in the FKBP5-governing
negative feedback loop, have been discussed as a key endocrine
marker for mood disorders (Binder, 2009). In agreement with
this hypothesis, a recent study revealed differences in gene expression profile responses in depressed patients versus healthy controls
using a dexamethasone-suppression test (Menke et al., 2013),
a tool commonly used to measure GR resistance. This study
revealed that depressed patients had much higher cortisol levels
21 h following dexamethasone (dex) intake compared to controls, suggesting GR resistance in depressed patients. This is in
contrast to the enhanced GR-sensitivity typically seen in PTSD
patients. Further, this study explored gene expression profiles
from peripheral blood accompanying dex treatment. It was found
that depressed patients had reduced levels of FKBP5 following dex treatment compared to controls, a pattern of findings
which suggest impaired GR sensitivity and FKBP5 expression in
depressed patients. Additionally these findings confirm the usefulness of dexamethasone-stimulated gene expression profiles as
a biomarker tool to uncover depression-related alterations in GR
reactivity.
Animal models of stress have also noted a role for FKBP5 in
coping behaviors and in the mediation of stress effects. Studies employing FKBP5 knockout mice have demonstrated reduced
HPA reactivity and highlighted a role for FKBP5 in mediating
coping behaviors to stress (Touma et al., 2011; Hartmann et al.,
2012). Further, a study employing a chronic corticosterone exposure paradigm, previously shown to result in a phenotype similar
to chronic stress exposure (Gourley et al., 2009) demonstrated an
increase in FKBP5 mRNA in the hippocampus, hypothalamus, and
blood of mice with a correspondent decrease in FKBP5 intron 5
DNA methylation (Lee et al., 2010). This group further determined
that this chronic corticosterone exposure paradigm also resulted in
alterations in FKBP5 methylation, as evident from blood samples
which correlated with glucocorticoid load and with anxiety-like
behaviors as measured by time spent in the closed arms of an
elevated plus maze (Lee et al., 2011). Thus these findings highlight the consequences of prolonged corticosterone exposure on
levels of FKBP5 and the ability to correlate epigenetic modifications of FKBP5 in blood samples with behavioral consequences
associated with a stress phenotype. Moreover, FKBP5 mRNA has
been shown to be increased following stress, especially in areas
already associated with stress and emotional reactivity, including
the paraventricular nucleus, central nucleus of the amygdala, and
hippocampus, regions which express low basal levels of FKBP5
mRNA (Scharf et al., 2011). However, it is important to note
that studies in humans have revealed lower levels of FKBP5 and
GR mRNA in the amygdala of suicide victims (Perez-Ortiz et al.,
2012) and lower levels of FKBP5 mRNA in the blood of PTSD
patients (Yehuda et al., 2009). These data suggest that further work
is needed to address the mechanisms through which shortened
stress exposure as is likely in animals models leads to an increase
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in FKBP5 expression, while chronic and longer lasting stress, as
is likely the case in human suicide victims result in a reduction
of FKBP5. Despite this potential contradiction, these findings further suggest that FBKP5 is critical for stress reactivity, and that
prior-stress experience may impair levels of FKBP5 to result in
poor adaptation to future stress. Additionally, as was mentioned
above, human patients with depression have been consistently
found to have GR non-responsiveness and those with PTSD to
have GR hypersensitivity. Some of the differences in these studies
may actually be due to increased FKBP5 function associated with
GR non-responsiveness, and decreased FKBP5 associated with GR
hypersensitivity. Thus, the apparent variance across studies may
be due to our yet incomplete understanding of the differential
biology of depression vs. PTSD.
In light of these findings, nice parallels can be seen in work
examining FKBP5 polymorphisms and the epigenetic regulation
of FKBP5 in human populations. First, an association between the
FKBP5 polymorphism rs9470080 and its interaction with earlychildhood stress has been found in the risk for development of
PTSD in an African American population (Binder et al., 2008;
Xie et al., 2010). In support of this finding, distinct FKBP5 genotypes have been shown to define distinct PTSD subtypes, such
that while baseline cortisol levels were found to be reduced in
non-risk allele carrying PTSD patients, only patients carrying the
FKBP5 polymorphism risk-allele, rs9296158, show GR hypersensitivity as measured by increased dex suppression (Mehta et al.,
2011). Further evidence for a role of FKBP5 polymorphisms in risk
for PTSD development can be observed in a recent study which
demonstrated that FKBP5 genotype and methylation patterns are
associated with GR sensitivity and early-childhood trauma exposure (Klengel et al., 2013). The authors found that epigenetic
modifications which likely result from early-life trauma enhance
FKBP5 genotype-dependent effects on GR sensitivity and ultimately regulate risk or predisposition for the development of
PTSD or depression.
In further support of a role for glucocorticoid-system mediated alterations with PTSD, additional work has revealed a role for
epigenetic regulation of the gene encoding the GR Nr3c1, and its
polymorphism Bcl1 in fear, stress, and anxiety. A study revealed
that suicide victims with a history of early-childhood abuse have
differential DNA-methylation patterns around transcription start
sites within the Nr3c1 locus in the hippocampus, whereas no difference was observed between suicide-completers in the absence
of early-childhood abuse or control subjects (Suderman et al.,
2012). Moreover, suicide victims with a history of child abuse
have been found to have reduced hippocampal GR expression
and an increase in Nr3c1 promoter methylation (McGowan et al.,
2009). Additionally it has been demonstrated that increased Nr3c1
promoter methylation levels obtained from peripheral blood samples of bipolar disorder, manic depressive disorder, and PTSD
subjects correlate with the severity of childhood abuse (Perroud
et al., 2011). These findings are supported by additional studies
of DNA methylation of Nr3c1 where leukocyte DNA-methylation
pattern differences associated with early-childhood stress correlate
with attenuated cortisol responsiveness following a Dex/CRH test
(Tyrka et al., 2012).
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Examination of the impact and lasting influence of earlylife stress has revealed differential methylation patterns of the
Nr3c1 promoter obtained from peripheral blood samples in mothers and newborns from the Democratic Republic of the Congo
(Mulligan et al., 2012). In this region plagued with war, stressrelated to ongoing war was most highly correlated with low birth
weight. Further it was revealed from umbilical cord blood samples that newborns from stressed mothers have increased levels
of Nr3c1 promoter methylation (Mulligan et al., 2012). These
data are the first of which we are aware to show the earliest evidence of epigenetic modifications of the Nr3c1 gene associated
with early-life stress. These findings underlie the utility of these
biomarker approaches to identify epigenetic-modifications associated with early-life trauma which may influence susceptibility
for the future development of psychopathology including PTSD.
Additional support for a role of Nr3c1 in risk for PTSD comes
from a pair of studies demonstrating that individuals with the
Nr3c1 polymorphism Bcl1 have been shown to have enhanced
emotional memory recall (Ackermann et al., 2012), have lower
levels of basal plasma cortisol levels, and recall more traumatic
memories from time spent in intensive-care units following cardiac surgery (Hauer et al., 2011). However, it is worth noting
that a study examining GR polymorphisms in a cohort of Vietnam veterans found no association of genotype with alterations
in GR responsiveness, nor was any difference in baseline cortisol
level observed between PTSD and non-PTSD veterans (Bachmann
et al., 2005).
While no epigenetic modifications to the Nr3c1 gene itself have
been specifically linked to PTSD diagnosis, the mounting evidence
for a role of early-life stress in mediating susceptibility for the later
development of PTSD, evidence for epigenetic alterations associated with suicide, and data showing early-life stress mediation
of epigenetic modifications in Nr3c1 suggest that a critical link
may eventually be revealed. Further evidence for this potential
link comes from another study employing a biomarkers approach
which demonstrated lower levels of methylation of the TPR gene,
which has been linked to Nr3c1 transcription, in individuals with
PTSD (Smith et al., 2011).
The human clinical data discussed so far have parallels with
animal studies modeling the effects of stress on epigenetic modulation of genes as well as the impact of stress on future experience
with trauma. However, there have been some very interesting
findings revealing epigenetic modifications solely from human
cohorts which are worth mentioning. A series of studies from
the Detroit Neighborhood Health Study (DNHS) has revealed a
role for epigenetic modifications of SLC6A3 and SLC6A4, genes
which encode for dopamine and serotonin transporters, respectively (Koenen et al., 2011; Chang et al., 2012). Individuals with
a polymorphism of the SLC6A3 gene were found to be at risk
for the development of PTSD. However, individuals with methylation of this polymorphism were found to be at even greater
risk for PTSD (Chang et al., 2012), suggesting that epigenetic
alterations in the gene associated with the dopaminergic system
may underlie risk for PTSD. Further work from this group established a potential protective role for epigenetic modifications to
the SLC6A4 gene (Koenen et al., 2011). This study determined
that SLC6A4 hypermethylation was associated with protection
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from the influence of multiple traumas on risk for development of
PTSD, suggesting for the first time that epigenetic alterations may
be protective against PTSD development. While these data suggest epigenetic-modifications associated with dopaminergic and
serotonergic function in both risk and protection from PTSD
development, it is important to consider the possibility that epigenetic modifications from a single cohort, such as the DNHS,
may have a different epigenetic landscape than other cohorts due
to the influence of social and environmental factors which can
leave their mark on the epigenome. Therefore, as progress in
revealing epigenetic modifications in human cohorts continues,
there is a great need to examine the reliability of these modifications across multiple cohorts in order to make the most confident
predictions of potential risk factors associated with PTSD development. In agreement with this notion, work from the DNHS has
exposed an association between epigenetic alterations of inflammatory and immune response genes with PTSD risk (Uddin et al.,
2011a,b), a pattern of findings which has been replicated in an
inner-city Atlanta population (Smith et al., 2011) and suggests
that an increase in methylation of anti-inflammatory genes, but
decrease in methylation for pro-inflammatory genes is associated
with PTSD. Thus these data suggest, across cohorts, that inflammation response genes and epigenetic-modifications associated
with these genes may underlie PTSD.

FUTURE DIRECTIONS
Great progress has been made in revealing both dynamic regulation of epigenetic modifications including changes in histone
acetylation and DNA methylation, which underlie the initial formation of aversive and enduring fear memories in Pavlovian fear
paradigms, as well as the enduring epigenetic-modifications associated with early-life stress. While human studies have parallels
with these animal studies of early-life stress, very little (if anything
at all) is known about the presence of such dynamic epigenetic
regulation in humans accompanying the initial formation of traumatic memories. Additionally, while animal and post-mortem
studies have enabled the ability to demonstrate epigenetic modifications in the brain accompanying fear memory formation,
stress, or trauma exposure, it is unclear how these findings correlate to the recent emergence in biomarkers-based epigenetic
approaches.
As highlighted throughout the work presented, some foundational progress has been made in identifying a vital role
for the epigenetic mechanisms required for initial fear memory consolidation. Initial findings have also noted a role for
epigenetic mechanisms in fear memory reconsolidation and
while the translation of reconsolidation-based memory interventions to the clinic is still in its infancy, the emergence of
a role for epigenetics in memory reconsolidation opens up
an additional set of epigenetic-modifying compounds for use
in the clinic in combination with reconsolidation-based therapy. As rodent models of fear extinction learning have found
great translational support, these preliminary findings of epigenetic mediation of extinction also propose that epigeneticmodifying compounds may be beneficial for the treatment of
fear and anxiety disorders when administered in conjunction
with exposure-based psychotherapy. Finally, the translation of
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animal models examining epigenetic modifications related to
early-life stress into studies examining the epigenetic modifications of genes associated with risk for PTSD supports continued
research in the area such that therapeutic approaches targeting
these epigenetic modifications may be developed not only as
potential prevention options but to expand the current treatments
available.
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